Cutler Group LP Tandem Diabetes Care Inc Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$35.49 - $56.15 $6,068 - $9,601	171 New	171 $7,000
Q2 2022 Aug 04, 2022	SELL	$53.22 - $123.09 $76,902 - $177,865	-1,445 Reduced 99.59%	6 $0
Q1 2022 Apr 14, 2022	BUY	$101.89 - $150.09 $114,728 - $169,001	1,126 Added 346.46%	1,451 $168,000
Q2 2021 Jul 19, 2021	BUY	$77.0 - $100.19 $17,325 - $22,542	225 Added 225.0%	325 $31,000
Q4 2018 Feb 05, 2019	SELL	$28.45 - $40.65 $76,359 - $109,104	-2,684 Reduced 96.41%	100 $3,000
Q3 2018 Nov 07, 2018	BUY	$21.39 - $51.17 $27,464 - $65,702	1,284 Added 85.6%	2,784 $119,000
Q2 2018 Aug 10, 2018	SELL	$4.9 - $23.64 $490 - $2,364	-100 Reduced 6.25%	1,500 $33,000
Q4 2017 Jan 17, 2018	BUY	$2.24 - $8.2 $3,584 - $13,119	1,600	1,600 $3,000

354

71.9M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.28B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.